Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Type 2 DiabetesCoronary Heart Disease
Interventions
DRUG

pioglitazone

45 mg per day for 6 months

All Listed Sponsors
collaborator

Takeda Pharmaceuticals North America, Inc.

INDUSTRY

lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT01588470 - Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM) | Biotech Hunter | Biotech Hunter